Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: University of Southern California
Relapsing Remitting Multiple Sclerosis
United States
- Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVDActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
United States, Argentina, Australia, Austria, Belgium +38 more
Sponsor: Drugs for Neglected Diseases
Localized Cutaneous Leishmaniasis
Brazil, Panama
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Russia
Sponsor: Novartis Pharmaceuticals
Gastroenteropancreatic Neuroendocrine Tumor
Italy
Sponsor: Novartis Pharmaceuticals
Atherosclerotic Cardiovascular Disease
United Arab Emirates
- A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular DiseaseActive Not Recruiting
Sponsor: University of Oxford
Atherosclerotic Cardiovascular Disease
United States, United Kingdom
- Alpelisib And Sacituzumab Govitecan For Treatment Of Breast CancerActive Not Recruiting
Sponsor: University of Kansas Medical Center
Breast Cancer
United States
- An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPCActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Castration Resistant Prostate Cancer (mCRPC)
United States
Sponsor: Drugs for Neglected Diseases
Primary Visceral Leishmaniasis
India
- Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Endometrial Cancer
United States
Sponsor: Novartis Pharmaceuticals
Somatostatin Receptor Positive (SSTR+) · Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
United States, Canada, China, France, Germany +7 more
- Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in FranceActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis (MS)
France
Sponsor: Institut Claudius Regaud
Neuroblastoma
France
Sponsor: Novartis Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
China, France, Germany, Italy, Japan +3 more
Sponsor: Novartis Pharmaceuticals
Sickle Cell Disease
Switzerland
Sponsor: University of Birmingham
Polycythemia Vera
United Kingdom
Sponsor: European Society for Blood and Marrow Transplantation
Severe Aplastic Anemia
France, Italy, Netherlands, Spain, Switzerland +1 more
- 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAsActive Not Recruiting
Sponsor: Children's Hospital of Philadelphia
Ras/MAPK Pathway Vascular Anomalies · Vascular Anomalies · Vascular Anomaly
United States
- Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBMActive Not Recruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Glioblastoma Multiforme
United States
- A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseaseActive Not Recruiting
Sponsor: Tourmaline Bio, Inc., a Novartis Company
Thyroid Eye Disease
United States, Brazil, France, Italy, Jordan +6 more
Sponsor: Novartis Pharmaceuticals
Lymphoma · Leukemia · Off-label Indications
- 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAsActive Not Recruiting
Sponsor: Children's Hospital of Philadelphia
Vascular Anomalies · Vascular Anomaly · TIE2/PIK3CA Pathway Driven Vascular Anomalies
United States
Sponsor: Novartis Pharmaceuticals
Psoriasis · Metabolic Syndrome
Germany
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Carcinoma · Prostate Carcinoma Metastatic in the Bone · Stage IV Prostate Cancer AJCC v7
United States